Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong · Delayed Price · Currency is HKD 61.15
-2.45 (-3.85%)
Jul 9, 2026, 4:08 PM HKT
Shanghai Henlius Biotech Market Cap
Shanghai Henlius Biotech has a market cap or net worth of 33.23 billion as of July 9, 2026. Its market cap has increased by 24.29% in one year.
Market Cap
33.23B
Enterprise Value
36.30B
Revenue
7.42B
Ranking
n/a
PE Ratio
36.39
Stock Price
61.15
Market Cap Chart
Since September 25, 2019, Shanghai Henlius Biotech's market cap has increased from 26.66B to 33.23B, an increase of 24.66%. That is a compound annual growth rate of 3.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 33.23B | 7.19% |
| Dec 31, 2025 | 31.01B | 140.72% |
| Dec 31, 2024 | 12.88B | 70.50% |
| Dec 29, 2023 | 7.55B | 8.59% |
| Dec 30, 2022 | 6.96B | -41.95% |
| Dec 31, 2021 | 11.98B | -53.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sino Biopharmaceutical | 85.94B |
| RemeGen | 70.02B |
| 3SBio | 48.64B |
| Biocytogen Pharmaceuticals (Beijing) | 47.76B |
| Shanghai Junshi Biosciences | 37.49B |
| Genscript Biotech | 29.54B |
| InnoCare Pharma | 28.03B |
| Keymed Biosciences | 24.91B |